Earlier, Biotech entrepreneur Bryan Johnson, abruptly cut the discussion on WTF Podcast short, citing India’s air pollution ...

Indian doctor Shikhar Ganjoo criticized Bryan Johnson's commitment to anti-aging science after Johnson left Nikhil Kamath’s ...

Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

Biotech entrepreneur Bryan Johnson prematurely ended his podcast with Nikhil Kamath due to poor air quality in the recording ...

Bryan Johnson, the biotech entrepreneur known as the ‘Age reversing CEO’ or the ‘Anti-ageing influencer’ for his ext..|News ...

In November, virologist Beata Halassy announced to the world that she had cured her own breast cancer using a treatment ...

Explore how science, innovation, and consumer demand are transforming the pursuit of longevity, from groundbreaking research ...

It’s been just six weeks since the killing of United Healthcare CEO Brian Thompson ... Most notably, Johnson & Johnson announced that it would buy Intra-Cellular Therapies, whose drug Calypta ...

The first day of the J.P. Morgan Healthcare Conference is in the books, featuring high-profile deal announcements from Johnson & Johnson ... Fierce Biotech's day 1 coverage can be found here.

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other dividend ...

We recently compiled a list of the 10 Best Diversified Dividend Stocks To Buy Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...